NASDAQInformation TechnologyAerospace & DefenseSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Gross profit improvement through cost management | Gross profit rose from $42,000 to $67,000 in the same period. | Broken | gross profit falls below $67,000 by 2026-Q3 | Gross profit: $-46,000 FY2026-Q4; GAAP. Published target: >= $67,000 gross profit by 2026-Q3. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Source published Sep 25, 2026-46,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q4 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 5a34b368-d171-47d3-aab2-9b246463dc54. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Reduce operating losses | A primary condition in ASTROTECH CORP's published investment case. The stated target is operating loss improves toward less negative than -$3.45 million by 2026-Q3. | Broken | operating loss worsens beyond -$3.45 million by 2026-Q3 | Operating income: $-3.248M FY2026-Q4; GAAP. Published target: operating loss improves toward less negative than -$3.45 million by 2026-Q3. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Source published Sep 25, 2026-3,248,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q4 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 5a34b368-d171-47d3-aab2-9b246463dc54. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth from strategic partnerships | A primary condition in ASTROTECH CORP's published investment case. The stated target is >= $343,000 revenue by 2026-Q3. | Broken | revenue growth falls below $343,000 by 2026-Q3 | Revenue: $913,000 FY2026-Q4; GAAP. Published target: >= $343,000 revenue by 2026-Q3. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Source published Sep 25, 2026913,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q4 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 5a34b368-d171-47d3-aab2-9b246463dc54. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth thesis, not a proven compounder, because ASTC is loss-making and recent financial performance is weak. The thesis is in a watch state, with medium confidence and a cautious signal.
The valuation model shows ASTC at a 1.17 premium versus peers, while the expectations gap is negative, meaning expectations appear demanding relative to the evidence. The priced-in tag is justified, and no fragility gates were triggered, but that does not remove the risk from weak fundamentals.
Near term, weak performance relative to its industry cohort and erratic earnings surprises make the next results uncertain; the snapshot flags a 43% miss probability. Management has announced a potential sale of 1st Detect and early lunar resource and infrastructure plans, but neither has reported a direct financial contribution yet.
Over the multi-year view, execution on the 1st Detect sale and lunar initiatives is central, including whether the sale process unlocks strategic value and funds those plans. Near-term sector support could improve if the Fed cuts rates or HAWK continues to report strong results, while weaker HAWK results could remove that support.
For the next 1 to 3 years, ASTC’s thesis remains uncertain: new strategic plans are unproven, while the business is loss-making and recent results are weak. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.